Spero Therapeutics (SPRO)
(Delayed Data from NSDQ)
$1.31 USD
-0.08 (-5.76%)
Updated Aug 2, 2024 04:00 PM ET
After-Market: $1.31 0.00 (0.00%) 4:54 PM ET
3-Hold of 5 3
F Value F Growth D Momentum F VGM
Detailed Estimates
EPS Estimates
Earnings Date | *AMC8/5/24 |
---|---|
Current Quarter | -0.35 |
EPS Last Quarter | -0.24 |
Last EPS Surprise | -242.86% |
ABR | 1.67 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -1.27 |
Next Year | -1.29 |
EPS (TTM) | 0.51 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 9.80M | 9.80M | 39.17M | 55.50M |
# of Estimates | 1 | 1 | 1 | 1 |
High Estimate | 9.80M | 9.80M | 39.17M | 55.50M |
Low Estimate | 9.80M | 9.80M | 39.17M | 55.50M |
Year ago Sales | 2.72M | 25.47M | 103.78M | 39.17M |
Year over Year Growth Est. | 260.29% | -61.52% | -62.26% | 41.69% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.35 | -0.27 | -1.27 | -1.29 |
# of Estimates | 2 | 1 | 3 | 2 |
Most Recent Consensus | -0.25 | -0.27 | -1.10 | -0.87 |
High Estimate | -0.25 | -0.27 | -1.01 | -0.87 |
Low Estimate | -0.44 | -0.27 | -1.60 | -1.70 |
Year ago EPS | -0.23 | 0.02 | 0.43 | -1.27 |
Year over Year Growth Est. | -52.17% | -1,450.00% | -395.35% | -1.44% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.35 | -0.27 | -1.27 | -1.29 |
7 Days Ago | -0.35 | -0.27 | -1.27 | -1.29 |
30 Days Ago | -0.35 | -0.27 | -1.27 | -1.29 |
60 Days Ago | -0.35 | -0.27 | -1.27 | -1.29 |
90 Days Ago | -0.41 | -0.16 | -0.94 | -0.90 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.35 | -0.27 | -1.27 | -1.29 |
Zacks Consensus Estimate | -0.35 | -0.27 | -1.27 | -1.29 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.24 | 0.96 | 0.02 | -0.23 | NA |
Estimate | -0.07 | -0.18 | -0.15 | -0.29 | NA |
Difference | -0.17 | 1.14 | 0.17 | 0.06 | 0.30 |
Surprise | -242.86% | 633.33% | 113.33% | 20.69% | 131.12% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more